EDIT:NASDAQ
Editas Medicine Inc
$2.40
0.00%
(0.00) 1D
$2.38
arrow_downward
-0.95% (-0.023)bedtimeAfter hours
Closed: Oct 26, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.39
High
$2.44
Low
$2.36
Mkt. cap
368.59M
Avg. vol.
2.88M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.39
High
$2.44
Low
$2.36
Mkt. cap
368.59M
Avg. vol.
2.88M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
The Motley Fool
·
14 minutes ago
Is a Stock Market Crash Coming? What History Says a $10,000 Investment in an S&P 500 ETF Could Be Worth at the End of 2027.
Coinfomania
·
51 minutes ago
S&P 500 Closes at 7,677, Maintaining Key Support Level
Yahoo Finance
·
9 hours ago
The 2 S&P 500 Stocks That Could Possibly Hold Up the Whole Index if the AI Trade Collapses
MarketWatch
·
8 hours ago
Why Lumentum’s stock led the S&P 500 higher on Monday
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc